CGNX SEC Filing News — Cognex Corporation

Latest SEC filings for Cognex Corporation (CGNX) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-22.

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks in the United States, Europe, Greater China, and internationally. Its machine vision products are used to automate the manufacture and distribution of discrete items, such as mobile phones, automotive components, and e-commerce packages, by locating, identifying, inspecting, and measuring them. The company offers VisionPro software, a suite of patented …
Sector: Technology Industry: Scientific & Technical Instruments Market Cap: $9.3B CIK: 851205
20
Total Filings
0
Bullish Classifications
7
Bearish Classifications
7
Insider Transactions
3
Material Events (8-K)
2
Periodic Reports
Rule-based classifications for CGNX currently lean bearish. Of the 20 filing records displayed, 7 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
CGNX Filing Activity Snapshot 2026-05-06 — 2026-09-22
Insider Transactions (Form 4)
0 buys vs 4 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$28.83M
Willett Robert · 2026-05-07
423,478 shares · Form 144
Form 144 Notices
8
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 7 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 7 filings in this group are Form 4s for Cognex Corporation.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 7 insider filings shown, the breakdown is 4 open-market sale and 3 option exercise. 4 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×4
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Option exercise ×3
The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.
Form 4 Open-market sale Insider Selling 2026-08-12

CGNX insider Moschner Matthew (Director, CEO & President) sold 24,962 shares (~$1.60M)

Moschner Matthew, listed as Director, CEO & President at COGNEX CORP, reported an open-market sale of 24,962 CGNX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 1,600 $56.44 $90.3K
S Open-market sale 1,600 $65.36 $104.6K
M Option exercise 4,000 $51.49 $206.0K
S Open-market sale 4,000 $65.36 $261.4K
M Option exercise 4,000 $40.71 $162.8K
S Open-market sale 4,000 $63.62 $254.5K
M Option exercise 7,000 $42.84 $299.9K
S Open-market sale 7,000 $63.61 $445.3K
S Open-market sale 8,362 $63.62 $532.0K
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 4,000 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 7,000 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 4,000 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 1,600 — —
Filing: Form 4 (Insider Transaction) Insider: Moschner Matthew (Director, CEO & President) Shares: 24,962 Est. Value: $1.60M
Form 4 Option exercise Tax / Compensation Filing 2026-08-11

CGNX insider Form 4 filed for equity award, exercise, or tax withholding

Long Darren Marc (Vice President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 2,500 — —
F Tax withholding on vested shares 734 $66.89 $49.1K
M Option exercise derivative · Restricted Stock Unit 2,500 — —
Filing: Form 4 (Insider Transaction) Insider: Long Darren Marc (Vice President) Shares: 3,234
Form 4 Option exercise Tax / Compensation Filing 2026-08-11

CGNX insider Form 4 filed for equity award, exercise, or tax withholding

Moschner Matthew (Director, CEO & President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 4,999 — —
F Tax withholding on vested shares 2,218 $66.89 $148.4K
M Option exercise derivative · Restricted Stock Unit 4,999 — —
Filing: Form 4 (Insider Transaction) Insider: Moschner Matthew (Director, CEO & President) Shares: 7,217
Form 4 Open-market sale Insider Selling 2026-05-28

CGNX insider Long Darren Marc (Vice President) sold 20,252 shares (~$1.34M)

Long Darren Marc, listed as Vice President at COGNEX CORP, reported an open-market sale of 20,252 CGNX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 4,500 $56.44 $254.0K
S Open-market sale 4,500 $66.32 $298.4K
M Option exercise 8,675 $51.49 $446.7K
S Open-market sale 8,675 $66.32 $575.3K
M Option exercise 5,498 $49.12 $270.1K
S Open-market sale 5,498 $66.32 $364.6K
S Open-market sale 1,579 $66.52 $105.0K
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 31,095 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 34,271 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 20,328 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 16,658 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 5,498 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 23,981 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 8,675 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 8,675 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 4,500 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 4,500 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 7,231 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 10,758 — —
A Compensation award derivative · Restricted Stock Unit 2,500 — —
A Compensation award derivative · Restricted Stock Unit 3,169 — —
A Compensation award derivative · Restricted Stock Unit 9,080 — —
A Compensation award derivative · Restricted Stock Unit 11,211 — —
Filing: Form 4 (Insider Transaction) Insider: Long Darren Marc (Vice President) Shares: 20,252 Est. Value: $1.34M
Form 4 Open-market sale Insider Selling 2026-05-12

CGNX insider Fennell Mark (Chief Legal Officer &Secretary) sold 64,873 shares (~$4.35M)

Fennell Mark, listed as Chief Legal Officer &Secretary at COGNEX CORP, reported an open-market sale of 64,873 CGNX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 6,400 $51.49 $329.5K
S Open-market sale 6,400 $67.08 $429.3K
M Option exercise 18,296 $47.21 $863.8K
S Open-market sale 18,296 $67.08 $1.23M
M Option exercise 15,080 $39.44 $594.8K
S Open-market sale 15,080 $67.08 $1.01M
M Option exercise 6,634 $33.04 $219.2K
S Open-market sale 6,634 $67.08 $445.0K
M Option exercise 9,600 $56.44 $541.8K
S Open-market sale 9,600 $67.08 $644.0K
M Option exercise 4,000 $42.84 $171.4K
S Open-market sale 4,000 $67.08 $268.3K
S Open-market sale 4,863 $66.73 $324.5K
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 6,634 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 15,080 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 4,000 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 18,296 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 6,400 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 9,600 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 7,231 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 22,412 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 30,464 — —
A Compensation award derivative · Non-Qualified Stock Option (right to buy) 8,921 — —
A Compensation award derivative · Restricted Stock Unit 3,169 — —
A Compensation award derivative · Restricted Stock Unit 9,685 — —
A Compensation award derivative · Restricted Stock Unit 11,211 — —
Filing: Form 4 (Insider Transaction) Insider: Fennell Mark (Chief Legal Officer &Secretary) Shares: 64,873 Est. Value: $4.35M
Form 4 Open-market sale Insider Selling 2026-05-12

CGNX insider MACDONALD LAURA ANN (VP and PAO) sold 139,722 shares (~$9.28M)

MACDONALD LAURA ANN, listed as VP and PAO at COGNEX CORP, reported an open-market sale of 139,722 CGNX shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 6,634 $33.04 $219.2K
S Open-market sale 6,634 $66.80 $443.2K
M Option exercise 15,080 $39.44 $594.8K
S Open-market sale 15,080 $66.80 $1.01M
M Option exercise 12,196 $47.21 $575.8K
S Open-market sale 12,196 $66.80 $814.7K
M Option exercise 17,000 $50.94 $866.0K
S Open-market sale 17,000 $66.80 $1.14M
M Option exercise 30,000 $51.49 $1.54M
S Open-market sale 30,000 $66.80 $2.00M
M Option exercise 15,000 $56.44 $846.6K
S Open-market sale 15,000 $66.80 $1.00M
S Open-market sale 2,212 $66.80 $147.8K
M Option exercise 6,100 $47.21 $288.0K
S Open-market sale 6,100 $65.56 $399.9K
M Option exercise 10,000 $48.28 $482.8K
S Open-market sale 10,000 $65.56 $655.6K
M Option exercise 25,500 $50.94 $1.30M
S Open-market sale 25,500 $65.56 $1.67M
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 6,634 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 15,080 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 12,196 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 6,100 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 10,000 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 17,000 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 25,500 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 30,000 — —
M Option exercise derivative · Non-Qualified Stock Option (right to buy) 15,000 — —
Filing: Form 4 (Insider Transaction) Insider: MACDONALD LAURA ANN (VP and PAO) Shares: 139,722 Est. Value: $9.28M
Form 4 Option exercise Tax / Compensation Filing 2026-05-08

CGNX insider Form 4 filed for equity award, exercise, or tax withholding

Fehr Dennis (SVP, Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 5,394 — —
F Tax withholding on vested shares 1,984 $62.26 $123.5K
M Option exercise derivative · Restricted Stock Unit 5,394 — —
Filing: Form 4 (Insider Transaction) Insider: Fehr Dennis (SVP, Chief Financial Officer) Shares: 7,378
Proposed Insider Sales 8 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Cognex Corporation has 8 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-08-11

CGNX Form 144 filed for proposed insider sale by MATTHEW MOSCHNER (24,962 shares) ~$1.61M

MATTHEW MOSCHNER filed a Form 144 with the SEC indicating intent to sell CGNX (COGNEX CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: MATTHEW MOSCHNER Shares: 24,962 Est. Value: $1.61M
Form 144 Large Proposed Insider Sale 2026-06-30

CGNX Form 144 filed for proposed insider sale by Willett Robert (172,667 shares) ~$12.32M

Willett Robert filed a Form 144 with the SEC indicating intent to sell CGNX (COGNEX CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Willett Robert Shares: 172,667 Est. Value: $12.32M
Form 144 Proposed Insider Sale 2026-06-29

CGNX Form 144 filed for proposed insider sale by Willett Robert (8,576 shares) ~$596.1K

Willett Robert filed a Form 144 with the SEC indicating intent to sell CGNX (COGNEX CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Willett Robert Shares: 8,576 Est. Value: $596.1K
Form 144 Proposed Insider Sale 2026-05-27

CGNX Form 144 filed for proposed insider sale by DARREN LONG (20,252 shares) ~$1.34M

DARREN LONG filed a Form 144 with the SEC indicating intent to sell CGNX (COGNEX CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: DARREN LONG Shares: 20,252 Est. Value: $1.34M
Form 144 Proposed Insider Sale 2026-05-12

CGNX Form 144 filed for proposed insider sale by MACDONALD LAURA ANN (41,600 shares) ~$2.73M

MACDONALD LAURA ANN filed a Form 144 with the SEC indicating intent to sell CGNX (COGNEX CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: MACDONALD LAURA ANN Shares: 41,600 Est. Value: $2.73M
Form 144 Proposed Insider Sale 2026-05-11

CGNX Form 144 filed for proposed insider sale by MARK FENNELL (64,873 shares) ~$4.35M

MARK FENNELL filed a Form 144 with the SEC indicating intent to sell CGNX (COGNEX CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: MARK FENNELL Shares: 64,873 Est. Value: $4.35M
Form 144 Large Proposed Insider Sale 2026-05-11

CGNX Form 144 filed for proposed insider sale by MACDONALD LAURA ANN (98,122 shares) ~$6.55M

MACDONALD LAURA ANN filed a Form 144 with the SEC indicating intent to sell CGNX (COGNEX CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: MACDONALD LAURA ANN Shares: 98,122 Est. Value: $6.55M
Form 144 Large Proposed Insider Sale 2026-05-07

CGNX Form 144 filed for proposed insider sale by Willett Robert (423,478 shares) ~$28.83M

Willett Robert filed a Form 144 with the SEC indicating intent to sell CGNX (COGNEX CORP) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Willett Robert Shares: 423,478 Est. Value: $28.83M
Material Events 3 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 3 in this period for Cognex Corporation. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-22

CGNX filed 8-K — material company event

COGNEX CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-08-05

CGNX filed 8-K — material company event

COGNEX CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-05-06

CGNX filed 8-K — material company event

COGNEX CORP filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Periodic Reports 2 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 2 quarterly reports (10-Q) for Cognex Corporation.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-06

CGNX filed Quarterly Report (10-Q)

COGNEX CORP filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
Form 10-Q Quarterly Report 2026-05-07

CGNX filed Quarterly Report (10-Q)

COGNEX CORP filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

How we classify Cognex Corporation's filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on CGNX. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — CGNX SEC Filings

More Tools for CGNX

Want deeper CGNX analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the CGNX stock analysis page.

CGNX Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer